Skip to main content
. 2021 Jun 22;22(13):6679. doi: 10.3390/ijms22136679

Table 2.

The summarized results of antimicrobial properties of the tested lipopeptides.

Compound MIC100 [µg/mL]
C.albicans
CCM 8186
C.krusei
CCM 8271
C.parapsilosis
CCM 8260
C.glabrata
CCM 8270
B. subtilis
PCM 2224
B. cereus
PCM 482
S. epidermidis
PCM 2118
S. aureus
PCM 2054
E. coli
PCM 2057
P. aeruginosa
PCM 499
C5-CAR Non-inhibitory
AHX-CAR
C12-CAR
C16-CAR
C5-DK5 6.25 25 3.13 6.25 0.78 12.5 0.78 12.5 3.13 25
AHX-DK5 12.5 50 12.5 12.5 0.78 50 0.78 >50 12.5 25
C12-DK5 3.13 3.13 3.13 3.13 0.78 12.5 0.78 6.25 12.5 12.5
C16-DK5 >50 6.25 12,5 >50 3.13 >50 25 >50 >50 >50
C5-CAR-PEG-DK5 >50 >50 50 >50 6.25 >50 6.25 >50 >50 >50
AHX-CAR-PEG-DK5 >50 >50 50 >50 6.25 >50 6.25 >50 >50 >50
C12-CAR-PEG-DK5 12.5 12.5 3.13 12.5 3.13 >50 0.78 6.25 3.13 12.5
C16-CAR-PEG-DK5 25 12.5 6.25 >50 12.5 >50 25 >50 >50 >50
DK5 31.3 7.8 31.3 62.5 15.6 >50 7.8 >50 >50 50
CAR-PEG-DK5 15.6 3.9 31.3 62.5 3.9 >50 3.9 >50 >50 50